Anti-ZEBOV VP35 Polyclonal Antibody from ProteoGenix; catalogue ARO-A22414; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Anti-ZEBOV VP35 Polyclonal Antibody
The Anti-ZEBOV VP35 Polyclonal Antibody is a highly effective tool for researchers studying the Ebola virus. This antibody specifically targets the VP35 protein, which is a key component of the Ebola virus responsible for its replication and pathogenesis.
The VP35 protein plays a critical role in the Ebola virus life cycle by acting as a viral polymerase cofactor and suppressing the host’s immune response. By targeting this protein, the Anti-ZEBOV VP35 Polyclonal Antibody can inhibit the replication of the virus and potentially prevent or treat Ebola infections.
The Anti-ZEBOV VP35 Polyclonal Antibody is primarily used in research related to the Ebola virus. It can be used in various techniques such as western blotting, immunofluorescence, and immunohistochemistry to detect and quantify the VP35 protein in infected cells or tissues. This antibody can also be used in functional studies to investigate the role of VP35 in the virus life cycle.
Recent studies have shown that the Anti-ZEBOV VP35 Polyclonal Antibody is effective in blocking the replication of the Ebola virus in cell culture models. It has also been used to successfully neutralize the virus in animal models, suggesting its potential as a therapeutic agent. Additionally, this antibody has been used to identify and characterize VP35 mutations that may contribute to the virus’s ability to evade the host’s immune response.
In summary, the Anti-ZEBOV VP35 Polyclonal Antibody is a valuable tool for researchers studying the Ebola virus. Its ability to specifically target the VP35 protein and its potential as a therapeutic agent make it a crucial component in the fight against this deadly virus. Order now and advance your research on Ebola virus pathogenesis and treatment.
ProteoGenix catalogue number ARO-A22414. For research use only.
Target: Polymerase cofactor VP35, Ebola VP35, eVP35, VP35; Clonality: Polyclonal Antibody; Applications: IHC, ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| Polymerase cofactor VP35, Ebola VP35, eVP35, VP35 |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
